US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

19.21

+0.14500.76%

Volume:803.15K

Turnover:15.29M

Market Cap:1.22B

PE:-8.20

High:19.33

Open:18.82

Low:18.59

Close:19.06

52wk High:28.00

52wk Low:6.91

Shares:63.60M

Float Shares:47.12M

Volume Ratio:1.00

T/O Rate:1.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3433

EPS(LYR):-3.1931

ROE:-89.18%

ROA:-33.59%

PB:0.42

PE(LYR):-6.01

Loading ...

Overview Company News Filings

JADE101 Phase 1 Trial Marks Key Early Milestone for Jade Biosciences Investors

BUZZ-U.S. STOCKS ON THE MOVE-UnitedHealth, Pinterest, Celcuity

Jade Biosciences 10M share Secondary priced at $15.00

Jade Biosciences prices 10 million-share follow-on at $15, raising $150 million gross

Jade Biosciences - Public Offering Priced at $15 per Share

THOMSON REUTERS

Press Release: Jade Biosciences Announces Pricing of Public Offering of Common Stock

BUZZ-Jade Biosciences falls on planned equity offering

Jade Biosciences Plans Public Offering

MT Newswires Live

Jade Biosciences announces common stock offering, no amount given

Jade Biosciences plans underwritten public offering of common stock, pre-funded warrants

Jade Biosciences - Net Proceeds to Fund Clinical Trials, Preclinical Studies, and Corporate Purposes

THOMSON REUTERS

Jade Biosciences Announces Proposed Underwritten Public Offering

THOMSON REUTERS

Wedbush Keeps Their Buy Rating on Jade Biosciences (JBIO)

Harrison Lifts JBIO Price Target to $74 on Promising JADE101 Data and Attractive IgA Nephropathy Opportunity

Jefferies says Jade Biosciences JADE101 data came in line with bull case

Wedbush Raises Price Target on Jade Biosciences to $45 From $34, Maintains Outperform Rating

MT Newswires Live

Jade Biosciences Is Maintained at Buy by HC Wainwright & Co.

Analysts Are Bullish on Top Healthcare Stocks: Aligos Therapeutics (ALGS), Jade Biosciences (JBIO)

Jade Biosciences, Inc. : H.c. Wainwright Raises Target Price to $55 From $45

THOMSON REUTERS

Jade Biosciences Reports Positive Interim Results in Trial of IgA Nephropathy Drug; Shares Rise

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/JBIO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"JBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":19.205,"timestamp":1789066489684,"preClose":19.06,"halted":0,"volume":803148,"delay":0,"changeRate":0.007607555089192003,"floatShares":47122000,"shares":63597387,"eps":-2.343303,"marketStatus":"Trading","change":0.145,"latestTime":"09-10 14:54:53 EDT","open":18.82,"high":19.33,"low":18.59,"amount":15288106.100892002,"amplitude":0.038825,"askPrice":19.27,"askSize":100,"bidPrice":19.17,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.343303,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":19.06,"preHourTrading":{"tag":"盘前","latestPrice":18.85,"preClose":19.06,"latestTime":"09:29 EDT","volume":642,"amount":12054.91746,"timestamp":1789046999999,"change":-0.21,"changeRate":-0.011018,"amplitude":0.103882},"postHourTrading":{"tag":"盘后","latestPrice":19.06,"preClose":19.06,"latestTime":"16:43 EDT","volume":18429,"amount":350918.49,"timestamp":1788986595969,"change":0,"changeRate":0,"amplitude":0.02256},"volumeRatio":0.99852,"impliedVol":1.1271,"impliedVolPercentile":0.8247},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","floatShares":47122000,"roa":"-33.59%","roe":"-89.18%","lyrEps":-3.193116,"volumeRatio":0.99852,"shares":63597387,"dividePrice":0,"high":19.33,"amplitude":0.038825,"preClose":19.06,"low":18.59,"week52Low":6.91,"pbRate":"0.42","week52High":28,"institutionHeld":0,"latestPrice":19.205,"committee":0.333333,"eps":-2.343303,"divideRate":0,"volume":803148,"delay":0,"ttmEps":-2.343303,"open":18.82,"prevYearClose":15.43,"prevWeekClose":19.9,"prevMonthClose":21.36,"prevQuarterClose":22.22,"fiveDayClose":21.4,"twentyDayClose":23.21,"sixtyDayClose":16.1,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.15429122468659595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"JBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2026-05-07","symbol":"JBIO","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2026-03-06","symbol":"JBIO","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772773200000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-11-13","symbol":"JBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-08-13","symbol":"JBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JBIO\",market:\"US\",,,undefined,":[{"executeDate":"2025-04-29","recordDate":"2025-04-25","paymentDate":"2025-04-28","value":2.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5455,"buy":0.4545,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5455,"analysts":11,"updateTime":1781496000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JBIO","date":"2026-09-08","current":-8.133818,"percent":0.250755,"low":-10.392766,"twenty":-8.850769,"median":-6.304711,"eighty":-2.846934,"high":-2.319279,"avg":-5.897659,"sd":2.682674,"marketCap":1265588001},"quantilePoints":[{"date":"2025-05-16","current":-2.4743,"twenty":-2.881556,"median":-2.868851,"eighty":-2.514424,"marketCap":232480279},{"date":"2025-05-23","current":-2.511409,"twenty":-2.870857,"median":-2.517932,"eighty":-2.47965,"marketCap":235966978},{"date":"2025-05-30","current":-2.432499,"twenty":-2.695315,"median":-2.507901,"eighty":-2.466944,"marketCap":228552715},{"date":"2025-06-06","current":-2.363881,"twenty":-2.548988,"median":-2.487393,"eighty":-2.464507,"marketCap":222105530},{"date":"2025-06-13","current":-2.381035,"twenty":-2.548988,"median":-2.48419,"eighty":-2.428382,"marketCap":223717326},{"date":"2025-06-20","current":-3.228464,"twenty":-2.618978,"median":-2.48419,"eighty":-2.41603,"marketCap":303340063},{"date":"2025-06-27","current":-3.17357,"twenty":-2.886906,"median":-2.487393,"eighty":-2.426323,"marketCap":298182315},{"date":"2025-07-03","current":-3.822008,"twenty":-3.217485,"median":-2.511409,"eighty":-2.437181,"marketCap":359108215},{"date":"2025-07-11","current":-3.609293,"twenty":-3.553713,"median":-2.554094,"eighty":-2.45809,"marketCap":339121941},{"date":"2025-07-18","current":-3.262773,"twenty":-3.420594,"median":-2.844205,"eighty":-2.467494,"marketCap":306563656},{"date":"2025-07-25","current":-2.857929,"twenty":-3.391775,"median":-2.873866,"eighty":-2.470924,"marketCap":268525263},{"date":"2025-08-01","current":-2.466808,"twenty":-3.382854,"median":-2.844205,"eighty":-2.467494,"marketCap":231776307},{"date":"2025-08-08","current":-2.511409,"twenty":-3.347859,"median":-2.705254,"eighty":-2.467494,"marketCap":235966978},{"date":"2025-08-15","current":-2.350869,"twenty":-3.260028,"median":-2.645214,"eighty":-2.467494,"marketCap":220882962},{"date":"2025-08-22","current":-2.56269,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"marketCap":240785267},{"date":"2025-08-29","current":-2.805764,"twenty":-3.217485,"median":-2.645214,"eighty":-2.470924,"marketCap":263623978},{"date":"2025-09-05","current":-2.70159,"twenty":-3.17357,"median":-2.64603,"eighty":-2.473669,"marketCap":253835959},{"date":"2025-09-12","current":-2.694645,"twenty":-3.152985,"median":-2.64603,"eighty":-2.4743,"marketCap":253183424},{"date":"2025-09-19","current":-2.677282,"twenty":-3.087798,"median":-2.64603,"eighty":-2.473669,"marketCap":251552088},{"date":"2025-09-26","current":-2.798819,"twenty":-3.080936,"median":-2.64603,"eighty":-2.4743,"marketCap":262971443},{"date":"2025-10-03","current":-2.892576,"twenty":-3.080936,"median":-2.67381,"eighty":-2.479351,"marketCap":271780660},{"date":"2025-10-10","current":-3.264131,"twenty":-3.152985,"median":-2.690514,"eighty":-2.480987,"marketCap":306691262},{"date":"2025-10-17","current":-3.397822,"twenty":-3.16343,"median":-2.70159,"eighty":-2.487393,"marketCap":319252553},{"date":"2025-10-24","current":-3.448173,"twenty":-3.228464,"median":-2.743259,"eighty":-2.487393,"marketCap":323983428},{"date":"2025-10-31","current":-3.420393,"twenty":-3.264131,"median":-2.760622,"eighty":-2.487393,"marketCap":321373290},{"date":"2025-11-07","current":-3.10787,"twenty":-3.295384,"median":-2.802291,"eighty":-2.501116,"marketCap":292009233},{"date":"2025-11-14","current":-3.361361,"twenty":-3.350943,"median":-2.840774,"eighty":-2.504393,"marketCap":315826746},{"date":"2025-11-21","current":-5.620897,"twenty":-3.393147,"median":-2.85789,"eighty":-2.511409,"marketCap":528128273},{"date":"2025-11-28","current":-6.276995,"twenty":-3.403031,"median":-2.873866,"eighty":-2.511409,"marketCap":589773908},{"date":"2025-12-05","current":-6.071353,"twenty":-3.439839,"median":-2.892576,"eighty":-2.514154,"marketCap":570452142},{"date":"2025-12-12","current":-7.266038,"twenty":-3.474564,"median":-2.963052,"eighty":-2.522532,"marketCap":682702402},{"date":"2025-12-19","current":-8.108193,"twenty":-3.595569,"median":-2.993278,"eighty":-2.527742,"marketCap":761829634},{"date":"2025-12-26","current":-8.093505,"twenty":-3.607234,"median":-3.022611,"eighty":-2.532681,"marketCap":760449508},{"date":"2026-01-02","current":-7.554917,"twenty":-3.822008,"median":-3.080936,"eighty":-2.536797,"marketCap":709844883},{"date":"2026-01-09","current":-6.487534,"twenty":-5.801079,"median":-3.116551,"eighty":-2.545612,"marketCap":609555716},{"date":"2026-01-16","current":-7.197491,"twenty":-6.02239,"median":-3.152985,"eighty":-2.555745,"marketCap":676261813},{"date":"2026-01-23","current":-8.333421,"twenty":-6.159485,"median":-3.153012,"eighty":-2.557134,"marketCap":782991569},{"date":"2026-01-30","current":-7.530436,"twenty":-6.394505,"median":-3.1685,"eighty":-2.564099,"marketCap":707544672},{"date":"2026-02-06","current":-7.045707,"twenty":-6.577625,"median":-3.177319,"eighty":-2.571103,"marketCap":662000509},{"date":"2026-02-13","current":-7.251349,"twenty":-6.621691,"median":-3.225463,"eighty":-2.577189,"marketCap":681322276},{"date":"2026-02-20","current":-7.124047,"twenty":-6.808238,"median":-3.251382,"eighty":-2.579625,"marketCap":669361182},{"date":"2026-02-27","current":-7.128943,"twenty":-6.986952,"median":-3.264131,"eighty":-2.583458,"marketCap":669821224},{"date":"2026-03-06","current":-6.795998,"twenty":-6.986952,"median":-3.314482,"eighty":-2.597415,"marketCap":638538365},{"date":"2026-03-13","current":-5.364757,"twenty":-6.933093,"median":-3.361361,"eighty":-2.602624,"marketCap":683523737},{"date":"2026-03-20","current":-5.449912,"twenty":-6.913508,"median":-3.389716,"eighty":-2.60436,"marketCap":694373320},{"date":"2026-03-27","current":-5.399593,"twenty":-6.874338,"median":-3.399558,"eighty":-2.630404,"marketCap":687962203},{"date":"2026-04-02","current":-6.200823,"twenty":-6.843002,"median":-3.403031,"eighty":-2.640126,"marketCap":790046917},{"date":"2026-04-10","current":-7.056243,"twenty":-6.843002,"median":-3.432606,"eighty":-2.644683,"marketCap":899035912},{"date":"2026-04-17","current":-8.46904,"twenty":-6.943865,"median":-3.47248,"eighty":-2.645867,"marketCap":1079040359},{"date":"2026-04-24","current":-9.757975,"twenty":-7.080959,"median":-3.477689,"eighty":-2.64603,"marketCap":1243263595},{"date":"2026-05-01","current":-9.451524,"twenty":-7.125026,"median":-3.585277,"eighty":-2.656356,"marketCap":1204218641},{"date":"2026-05-08","current":-9.381799,"twenty":-7.197491,"median":-3.600715,"eighty":-2.670835,"marketCap":1195335061},{"date":"2026-05-15","current":-9.189592,"twenty":-7.279748,"median":-3.609293,"eighty":-2.676588,"marketCap":1191053783},{"date":"2026-05-22","current":-8.934431,"twenty":-7.436993,"median":-3.822008,"eighty":-2.684564,"marketCap":1157982667},{"date":"2026-05-29","current":-7.936639,"twenty":-7.480494,"median":-5.132517,"eighty":-2.691341,"marketCap":1028659795},{"date":"2026-06-05","current":-6.756045,"twenty":-7.480494,"median":-5.23899,"eighty":-2.696728,"marketCap":875644182},{"date":"2026-06-12","current":-7.36451,"twenty":-7.480494,"median":-5.370563,"eighty":-2.700201,"marketCap":954506790},{"date":"2026-06-18","current":-7.726324,"twenty":-7.487348,"median":-5.393787,"eighty":-2.710604,"marketCap":1001401091},{"date":"2026-06-26","current":-9.988804,"twenty":-7.591639,"median":-5.407335,"eighty":-2.731778,"marketCap":1294638873},{"date":"2026-07-02","current":-9.988804,"twenty":-7.673406,"median":-5.426688,"eighty":-2.743259,"marketCap":1294638873},{"date":"2026-07-10","current":-10.295658,"twenty":-7.795377,"median":-5.444106,"eighty":-2.744648,"marketCap":1334409990},{"date":"2026-07-17","current":-9.379675,"twenty":-7.921008,"median":-5.585386,"eighty":-2.752288,"marketCap":1215690240},{"date":"2026-07-24","current":-8.985802,"twenty":-8.046029,"median":-5.655171,"eighty":-2.766178,"marketCap":1164640747},{"date":"2026-07-31","current":-9.159838,"twenty":-8.108193,"median":-5.875502,"eighty":-2.788402,"marketCap":1187197500},{"date":"2026-08-07","current":-10.18574,"twenty":-8.267967,"median":-5.948946,"eighty":-2.798819,"marketCap":1320163620},{"date":"2026-08-14","current":-9.881583,"twenty":-8.338317,"median":-6.086042,"eighty":-2.805764,"marketCap":1514253784},{"date":"2026-08-21","current":-8.810836,"twenty":-8.64582,"median":-6.164381,"eighty":-2.819654,"marketCap":1350172526},{"date":"2026-08-28","current":-8.835737,"twenty":-8.844495,"median":-6.229853,"eighty":-2.840774,"marketCap":1353988369},{"date":"2026-09-04","current":-8.238111,"twenty":-8.852338,"median":-6.276995,"eighty":-2.844205,"marketCap":1262408131},{"date":"2026-09-08","current":-8.258862,"twenty":-8.850769,"median":-6.304711,"eighty":-2.846934,"marketCap":1265588001}],"updateTime":1789024805442},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JBIO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641696851","title":"JADE101 Phase 1 Trial Marks Key Early Milestone for Jade Biosciences Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641696851","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641696851?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:33","pubTimestamp":1780590793,"startTime":"0","endTime":"0","summary":"Jade Biosciences, Inc. ($JBIO) announced an update on their ongoing clinical study. Jade Biosciences, Inc. has launched a Phase 1 trial called “A S...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jade101-phase-1-trial-marks-key-early-milestone-for-jade-biosciences-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jade101-phase-1-trial-marks-key-early-milestone-for-jade-biosciences-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","BK4139","BK4539","ISBC","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640616695","title":"BUZZ-U.S. STOCKS ON THE MOVE-UnitedHealth,  Pinterest, Celcuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2640616695","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640616695?lang=en_us&edition=fundamental","pubTime":"2026-06-04 23:47","pubTimestamp":1780588020,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-UnitedHealth, Pinterest, Celcuity Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nL6N42C0WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMDU","AVL","LINT","NUE","COII","AMD","CRWL","FIAT","CELC","CSGP","COIN","DDD","AVY","MARA","BIIB","RTX","COIG","LFTO","AVGX","AEVA","RIOT","COIW","HUT","AVEX","ZTS","INTC","RTXG","STLD","JBIO","SSMR","BTSG","CRWD","COIA","HON","UNH","SNDX","CONL","CONI","CONY","SNBR","DAMD","COIO","RTYY","GUTS","MARO","FIVE","AVGO","CONX","ICOI","PINS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640615156","title":"Jade Biosciences 10M share Secondary priced at $15.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2640615156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640615156?lang=en_us&edition=fundamental","pubTime":"2026-06-04 18:37","pubTimestamp":1780569453,"startTime":"0","endTime":"0","summary":"Jefferies, TD Cowen and UBS acted as joint book running managers for the offering. Published first on TheFly – the ultimate source for real-time, m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-10m-share-secondary-priced-at-15-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-10m-share-secondary-priced-at-15-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034235071.USD","LU1863844749.USD","BK4534","LU1863844665.USD","BK4585","JBIO","UBS","BK4539","LU3187612489.SGD","BK4588","LU1829250122.USD","BK4118","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640113644","title":"Jade Biosciences prices 10 million-share follow-on at $15, raising $150 million gross","url":"https://stock-news.laohu8.com/highlight/detail?id=2640113644","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640113644?lang=en_us&edition=fundamental","pubTime":"2026-06-04 10:58","pubTimestamp":1780541898,"startTime":"0","endTime":"0","summary":"Jade Biosciences priced a follow-on offering of 10,000,000 common shares at USD 15 per share.Gross proceeds expected at USD 150 million, excluding any exercise of the 1,500,000-share over-allotment option.Closing expected June 5, 2026, subject to customary conditions.Net proceeds earmarked for clinical trials, preclinical work, manufacturing support, R&D, capital spending, working capital, general corporate purposes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL8tW4xN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4112","BK4585","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4139","BK4588","IE00BN0W2W23.USD","SG9999014021.USD","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","JBIO","LU2095319765.USD","IE00BKPKM429.USD","SG9999014013.SGD","BK4539","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640364451","title":"Jade Biosciences - Public Offering Priced at $15 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2640364451","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640364451?lang=en_us&edition=fundamental","pubTime":"2026-06-04 10:58","pubTimestamp":1780541884,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA61174S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640362381","title":"Press Release: Jade Biosciences Announces Pricing of Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2640362381","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640362381?lang=en_us&edition=fundamental","pubTime":"2026-06-04 10:58","pubTimestamp":1780541880,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO and VANCOUVER, British Columbia, June 03, 2026  -- Jade Biosciences, Inc.  , a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the pricing of a public offering of 10,000,000 shares of its common stock. The shares of common stock are being sold to the public at a price of $15.00 per share. The gross proceeds to Jade from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $150.0 million, excluding any exercise of the underwriters' option to purchase additional shares. The offering is expected to close on June 5, 2026, subject to the satisfaction of customary closing conditions. In addition, Jade has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock to be sold in the p","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","JBIO","USA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640041184","title":"BUZZ-Jade Biosciences falls on planned equity offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640041184","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640041184?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:10","pubTimestamp":1780521015,"startTime":"0","endTime":"0","summary":"BUZZ-Jade Biosciences falls on planned equity offering** Jade Biosciences' JBIO.O shares down 6.2% after hours to $16.50 as it looks to raise equity** Autoimmune diseases-focused biotech announces offering comprised of stock and pre-funded warrants; deal size not disclosed** Jefferies, TD Cowen and UBS joint bookrunners** Co intends to use net offering proceeds to fund clinical trials, preclinical studies, R&D, and for capex, among other purposes** With ~49.4 mln shares outstanding, co has about $870 mln market cap** JBIO stock ended Weds down 0.9% at $17.59, up 14% YTD** 6 analysts rate the stock \"strong buy\", the other 4 \"buy\"; median PT of $43.50 up from $24.50 a month ago, according to LSEG data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nL6N42B1A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4139","JEF","JBIO","BK4539","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640618497","title":"Jade Biosciences Plans Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640618497","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640618497?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:51","pubTimestamp":1780519906,"startTime":"0","endTime":"0","summary":"Jade Biosciences  said late Wednesday it plans to offer shares, or pre-funded warrants to purchase shares, in an underwritten public offering.Jade said it intends to grant its underwriters a 30-day option to buy up to an additional 15% of the securities offered.Net proceeds will be used among others for clinical trials, pre-clinical studies, and working capital, the clinical-stage firm said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640103181","title":"Jade Biosciences announces common stock offering, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2640103181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640103181?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:05","pubTimestamp":1780517147,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in lieu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-announces-common-stock-offering-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-announces-common-stock-offering-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189743","title":"Jade Biosciences plans underwritten public offering of common stock, pre-funded warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189743","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189743?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:01","pubTimestamp":1780516901,"startTime":"0","endTime":"0","summary":"Jade Biosciences launched a proposed underwritten public offering of common stock or pre-funded warrants in lieu of common stock.Underwriters get a 30-day option to buy up to 15% more securities at the offering price, less discounts and commissions.Proceeds earmarked for clinical trials, preclinical studies, manufacturing support, research and development, capital spending, working capital.Jefferies, TD Cowen, UBS Investment Bank named joint book-runners; LifeSci Capital also a book-runner; BTIG lead manager.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL9nYVYd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","LU2210150020.SGD","BK4585","SG9999014021.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","LU0314104364.USD","BK4539","SG9999014039.USD","JBIO","IE00BN0W2V16.EUR","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189765","title":"Jade Biosciences - Net Proceeds to Fund Clinical Trials, Preclinical Studies, and Corporate Purposes","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189765?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:01","pubTimestamp":1780516860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1RTQKS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189762","title":"Jade Biosciences Announces Proposed Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189762?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:01","pubTimestamp":1780516860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1RTQKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640943300","title":"Wedbush Keeps Their Buy Rating on Jade Biosciences (JBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640943300","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640943300?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:38","pubTimestamp":1780403916,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico maintained a Buy rating on Jade Biosciences today and set a price target of $45.00. According to TipRanks, Chico is a 5...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917107","title":"Harrison Lifts JBIO Price Target to $74 on Promising JADE101 Data and Attractive IgA Nephropathy Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917107","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917107?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:16","pubTimestamp":1780398977,"startTime":"0","endTime":"0","summary":"BTIG analyst Julian Harrison has maintained their bullish stance on JBIO stock, giving a Buy rating yesterday. Julian Harrison has given his Buy ra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/harrison-lifts-jbio-price-target-to-74-on-promising-jade101-data-and-attractive-iga-nephropathy-opportunity-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/harrison-lifts-jbio-price-target-to-74-on-promising-jade101-data-and-attractive-iga-nephropathy-opportunity-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640961256","title":"Jefferies says Jade Biosciences JADE101 data came in line with bull case","url":"https://stock-news.laohu8.com/highlight/detail?id=2640961256","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640961256?lang=en_us&edition=fundamental","pubTime":"2026-06-02 03:40","pubTimestamp":1780342808,"startTime":"0","endTime":"0","summary":"Jefferies noted that Jade Biosciences (JBIO)’ interim JADE101 trial data hit the firm’s bull case expectations. The firm added that management sees...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jefferies-says-jade-biosciences-jade101-data-came-in-line-with-bull-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jefferies-says-jade-biosciences-jade101-data-came-in-line-with-bull-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640680719","title":"Wedbush Raises Price Target on Jade Biosciences to $45 From $34, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2640680719","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640680719?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:34","pubTimestamp":1780328080,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) has an average rating of buy and mean price target of $38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640462950","title":"Jade Biosciences Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2640462950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640462950?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:36","pubTimestamp":1780324560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 01, 2026 10:36 ET (14:36 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640761950","title":"Analysts Are Bullish on Top Healthcare Stocks: Aligos Therapeutics (ALGS), Jade Biosciences (JBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640761950","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640761950?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:30","pubTimestamp":1780324206,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aligos Therapeutics (ALGS) and Jade Biosciences (JBI...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-aligos-therapeutics-algs-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-aligos-therapeutics-algs-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","JBIO","BK4505","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640018951","title":"Jade Biosciences, Inc. : H.c. Wainwright Raises Target Price to $55 From $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2640018951","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640018951?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:42","pubTimestamp":1780317739,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nAZN4SZUDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640495920","title":"Jade Biosciences Reports Positive Interim Results in Trial of IgA Nephropathy Drug; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2640495920","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640495920?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:02","pubTimestamp":1780315356,"startTime":"0","endTime":"0","summary":"Jade Biosciences  said Monday that interim phase 1 trial results showed its experimental immunoglobulin A nephropathy treatment, JADE101, delivered rapid, deep and sustained reductions in IgA levels in healthy volunteers.The company said JADE101 achieved about 70% reductions in IgA levels that were sustained for 12 weeks at the 700 mg dose. The therapy was generally well tolerated across all tested dose levels, with no serious adverse events or study discontinuations reported, the company said.Jade said the data suggest JADE101 could potentially be administered once every 12 weeks, supporting a more convenient dosing schedule than existing therapies.Shares of Jade Biosciences were 9.8% higher in premarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":118,"code":"91000000","status":"200"}]}}